Cancellation Notification of the Public Teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 28697 [2017-13183]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 120 / Friday, June 23, 2017 / Notices
removed at any time. The Board meets
no less than twice per year.
The Board reports to the Secretary of
Labor. As specified in Section 3687(i),
the Board shall terminate five (5) years
after the date of the enactment of the
NDAA, which was December 19, 2014.
Thus, the Board shall terminate on
December 19, 2019.
Electronic copies of this Federal
Register notice are available at https://
www.regulations.gov. This notice, as
well as news releases and other relevant
information, are also available on the
Advisory Board’s Web page at https://
www.dol.gov/owcp/energy/regs/
compliance/AdvisoryBoard.htm.
You may contact Douglas Fitzgerald,
Designated Federal Officer, at
fitzgerald.douglas@dol.gov, or Carrie
Rhoads, Alternate Designated Federal
Officer, at rhoads.carrie@dol.gov, U.S.
Department of Labor, 200 Constitution
Avenue NW., Suite S–3524,
Washington, DC 20210, telephone (202)
343–5580.
This is not a toll-free number.
Signed at Washington, DC, this 16th day of
June, 2017.
Gary Steinberg,
Deputy Director, Office of Workers’
Compensation Programs.
[FR Doc. 2017–13202 Filed 6–22–17; 8:45 am]
BILLING CODE 4510–24–P
EXECUTIVE OFFICE OF THE
PRESIDENT
Office of National Drug Control Policy
Cancellation Notification of the Public
Teleconference of the President’s
Commission on Combating Drug
Addiction and the Opioid Crisis
(Commission)
Office of National Drug Control
Policy (ONDCP).
ACTION: Notice of cancellation of
teleconference.
AGENCY:
ONDCP is issuing this notice
to advise the public that the
Commission is cancelling the
teleconference of the President’s
Commission on Combating Drug
Addiction and the Opioid Crisis that
was previously scheduled for Monday,
June 26th at 4 p.m. EST. Please check
the Commission’s Web site or future
Federal Register notices for information
about when this meeting will be
rescheduled.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
The cancellation is effective on
June 20, 2017.
FOR FURTHER INFORMATION CONTACT:
General information concerning the
DATES:
VerDate Sep<11>2014
19:21 Jun 22, 2017
Jkt 241001
Commission and its meetings can be
found on ONDCP’s Web site at https://
www.whitehouse.gov/ondcp/presidentscommission. Any member of the public
wishing to obtain information about the
Commission or its meetings that is not
already on ONDCP’s Web site or who
wishes to submit written comments for
the Commission’s consideration may
contact Michael Passante, Designated
Federal Officer (DFO) via email at
commission@ondcp.eop.gov or
telephone at (202) 395–6709. Please
note that ONDCP may post such written
comments publicly on our Web site,
including names and contact
information that are submitted.
SUPPLEMENTARY INFORMATION: The
Commission was established in
accordance with E.O. 13784 of March
29, 2017, the Commission’s charter, and
the provisions of the Federal Advisory
Committee Act (FACA), as amended, 5
U.S.C. App. 2, to obtain advice and
recommendations for the President
regarding drug issues. The Executive
Order, charter, and information on the
Members of the Commission are
available on ONDCP’s Web site. The
Commission will function solely as an
advisory body and will make
recommendations regarding policies
and practices for combating drug
addiction with particular focus on the
current opioid crisis in the United
States. The Commission’s final report is
due October 1, 2017 unless there is an
extension. Per E.O. 13784, the
Commission shall:
a. Identify and describe the existing
Federal funding used to combat drug
addiction and the opioid crisis;
b. assess the availability and
accessibility of drug addiction treatment
services and overdose reversal
throughout the country and identify
areas that are underserved;
c. identify and report on best practices
for addiction prevention, including
healthcare provider education and
evaluation of prescription practices,
collaboration between State and Federal
officials, and the use and effectiveness
of State prescription drug monitoring
programs;
d. review the literature evaluating the
effectiveness of educational messages
for youth and adults with respect to
prescription and illicit opioids;
e. identify and evaluate existing
Federal programs to prevent and treat
drug addiction for their scope and
effectiveness, and make
recommendations for improving these
programs; and;
f. make recommendations to the
President for improving the Federal
response to drug addiction and the
opioid crisis.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
28697
Dated: June 20, 2017.
Michael Passante,
Acting General Counsel, Designated Federal
Officer.
[FR Doc. 2017–13183 Filed 6–22–17; 8:45 am]
BILLING CODE 3280–F5–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
National Endowment for the Arts
Submission for OMB Review;
Comment Request
The National Endowment for the Arts
(NEA) has submitted the following
public information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act of 1995: Applications
from students for Agency Initiatives
Poetry Out Loud or the Musical Theater
Songwriting Challenge for High School
Students. Copies of this ICR, with
applicable supporting documentation,
may be obtained by visiting
www.Reginfo.gov.
Comments should be sent to the
Office of Information and Regulatory
Affairs, Attn: OMB Desk Officer for the
National Endowment for the Arts, Office
of Management and Budget, Room
10235, Washington, DC 20503, 202/395–
7316, within 30 days from the date of
this publication in the Federal Register.
The Office of Management and Budget
(OMB) is particularly interested in
comments which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Could help minimize the burden of
the collection of information on those
who are to respond, including through
the use of electronic submission of
responses through Grants.gov.
SUPPLEMENTARY INFORMATION: The
National Endowment for the Arts
requests the review of applications from
students for Agency Initiatives Poetry
Out Loud or the Musical Theater
Songwriting Challenge for High School
Students. This entry is issued by the
National Endowment for the Arts and
contains the following information: (1)
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 82, Number 120 (Friday, June 23, 2017)]
[Notices]
[Page 28697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13183]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Cancellation Notification of the Public Teleconference of the
President's Commission on Combating Drug Addiction and the Opioid
Crisis (Commission)
AGENCY: Office of National Drug Control Policy (ONDCP).
ACTION: Notice of cancellation of teleconference.
-----------------------------------------------------------------------
SUMMARY: ONDCP is issuing this notice to advise the public that the
Commission is cancelling the teleconference of the President's
Commission on Combating Drug Addiction and the Opioid Crisis that was
previously scheduled for Monday, June 26th at 4 p.m. EST. Please check
the Commission's Web site or future Federal Register notices for
information about when this meeting will be rescheduled.
DATES: The cancellation is effective on June 20, 2017.
FOR FURTHER INFORMATION CONTACT: General information concerning the
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the
public wishing to obtain information about the Commission or its
meetings that is not already on ONDCP's Web site or who wishes to
submit written comments for the Commission's consideration may contact
Michael Passante, Designated Federal Officer (DFO) via email at
commission@ondcp.eop.gov or telephone at (202) 395-6709. Please note
that ONDCP may post such written comments publicly on our Web site,
including names and contact information that are submitted.
SUPPLEMENTARY INFORMATION: The Commission was established in accordance
with E.O. 13784 of March 29, 2017, the Commission's charter, and the
provisions of the Federal Advisory Committee Act (FACA), as amended, 5
U.S.C. App. 2, to obtain advice and recommendations for the President
regarding drug issues. The Executive Order, charter, and information on
the Members of the Commission are available on ONDCP's Web site. The
Commission will function solely as an advisory body and will make
recommendations regarding policies and practices for combating drug
addiction with particular focus on the current opioid crisis in the
United States. The Commission's final report is due October 1, 2017
unless there is an extension. Per E.O. 13784, the Commission shall:
a. Identify and describe the existing Federal funding used to
combat drug addiction and the opioid crisis;
b. assess the availability and accessibility of drug addiction
treatment services and overdose reversal throughout the country and
identify areas that are underserved;
c. identify and report on best practices for addiction prevention,
including healthcare provider education and evaluation of prescription
practices, collaboration between State and Federal officials, and the
use and effectiveness of State prescription drug monitoring programs;
d. review the literature evaluating the effectiveness of
educational messages for youth and adults with respect to prescription
and illicit opioids;
e. identify and evaluate existing Federal programs to prevent and
treat drug addiction for their scope and effectiveness, and make
recommendations for improving these programs; and;
f. make recommendations to the President for improving the Federal
response to drug addiction and the opioid crisis.
Dated: June 20, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-13183 Filed 6-22-17; 8:45 am]
BILLING CODE 3280-F5-P
